α-Glucosidase inhibitory activity of cannabidiol, tetrahydrocannabinol and standardized cannabinoid extracts from Cannabis sativa
Two major cannabinoids of cannabis, namely cannabidiol (CBD) and tetrahydrocannabinol (THC) have been reportedly used as alternative medicine for diabetes treatment in both pre-clinical and clinical research. However, their mechanisms of action still remain unclear. Therefore, this study aimed to ev...
Main Authors: | Wiwit Suttithumsatid, Muhammad Ajmal Shah, Shabana Bibi, Pharkphoom Panichayupakaranant |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Current Research in Food Science |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2665927122001046 |
Similar Items
-
Combinations of Cannabidiol and Δ<sup>9</sup>-Tetrahydrocannabinol in Reducing Chemotherapeutic Induced Neuropathic Pain
by: Diana E. Sepulveda, et al.
Published: (2022-10-01) -
Cannabis, Cannabidiol Oils and Tetrahydrocannabinol—What Do Veterinarians Need to Know?
by: Nancy De Briyne, et al.
Published: (2021-03-01) -
Recreational cannabis: Profile of cannabinoids present in marijuana samples supplied by the consuming population
by: Santiago Gómez Velásquez, et al.
Published: (2023-03-01) -
Priority areas for cannabis and cannabinoid product research in South Africa
by: Tanya N. Augustine, et al.
Published: (2018-06-01) -
Geotemporospatial and causal inference epidemiological analysis of US survey and overview of cannabis, cannabidiol and cannabinoid genotoxicity in relation to congenital anomalies 2001–2015
by: Albert Stuart Reece, et al.
Published: (2022-01-01)